Original Report

Perceptions about participation in cancer clinical trials in New York state


 

Background Clinical trials are valuable in advancing cancer care through the investigation of ways in which to better prevent, detect and diagnose, and/or treat cancer. Recruitment of adults into clinical trials has historically been low.

Objective To survey adult cancer patients who reside in New York state to better understand their participation in and attitudes about clinical trials.

Methods From January 2012-April 2013, we conducted a one-time survey about clinical trials in 8 cancer-treatment or cancer-patient support organizations in the state. Surveys were offered in person and online to adults with a past or current cancer diagnosis. Analysis was limited to adults who resided in the state and provided a self-reported status of previous participation in clinical trials.

Results Of the 1,832 participants who completed the survey, 1,475 were included in the analysis. Our sample represented all regions of the state. Most of the respondents (68.1%) had never participated in a clinical trial. Almost 32% said they had never received information about research studies. Most (84%) felt that patients should be asked to participate in clinical trials, but fewer (70%) were willing to be approached about participation.

Limitations The sample is predominantly white and female and overrepresents breast and hematologic cancers.

Conclusions Increased outreach coupled with a team approach to educate and enroll patients in clinical trials may be the necessary first steps to increase participation in trials and ensure a diverse sample of participants.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Rise in reports of pain, depression in last year of life in oncology patients
MDedge Hematology and Oncology
Guideline: Therapy for women with HER2­-negative or unknown advanced breast cancer
MDedge Hematology and Oncology
Guideline: Screening, assessment, and care of anxiety and depression in adults with cancer
MDedge Hematology and Oncology
Laser improves oral mucositis in breast cancer patients
MDedge Hematology and Oncology
Breast cancer patients show poor adherence to cardiovascular, diabetes medications
MDedge Hematology and Oncology
Physical signs indicate impending death in cancer patients
MDedge Hematology and Oncology
ASCO endorses ACS guidelines for prostate cancer survivor care
MDedge Hematology and Oncology
Study: Few oncology patients demand tests, procedures
MDedge Hematology and Oncology
Sustained antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of emetogenic chemotherapy
MDedge Hematology and Oncology
Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?
MDedge Hematology and Oncology